Sirnaomics

Sirnaomics is a clinical-stage biopharmaceutical company leveraging RNA interference (RNAi) technology to develop therapies for critical human diseases. RNAi technology is utilized to discover and develop new treatments, with a focus on oncology, anti-fibrotic therapies, and viral infections. Its proprietary peptide nanoparticle (PNP) technology is used for small interfering RNA (siRNA) drug delivery. This technology allows access to the tumor microenvironment (TME) as well as various cell types in the liver.